share_log

HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Raises Price Target to $17

Moomoo 24/7 ·  Mar 20 06:56

HC Wainwright & Co. analyst Robert Burns maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $16 to $17.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment